PCRX · NASDAQ · Drug Manufacturers - Specialty & Generic

Pacira BioSciences (PCRX)

Develops non-opioid pain and musculoskeletal treatments built on a liposome drug-delivery platform.

$24.75
vs last close+0.64 (+2.63%)